|
Volumn 139, Issue 5 Pt 1, 2003, Pages 313-320
|
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
PLACEBO;
RNA;
TENOFOVIR DISOPROXIL;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BLOOD;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MULTICENTER STUDY;
MUTATION;
RANDOMIZED CONTROLLED TRIAL;
VIROLOGY;
VIRUS LOAD;
ADENINE;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE, VIRAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MUTATION;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
PLACEBOS;
RNA;
VIRAL LOAD;
|
EID: 0141609130
PISSN: None
EISSN: 15393704
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (113)
|
References (0)
|